Abstract
BackgroundThe use of TNF-inhibitors and/or the IL-6 receptor antagonist, tocilizumab, in rheumatoid arthritis (RA) have pleiotropic effects that also involve circulating B-cells. The main goal of this study was to...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have